PERSEE Trial Settles the PD-L1-High NSCLC Debate? / cancer, Chantal Decroisette, chemo-immunotherapy, ESMO26, European ...
The Pfizer Atirmociclib Breast Cancer Research Grants 2027 support investigator-sponsored clinical studies evaluating ...
Endocrine therapy remains the backbone of HR-positive, HER2-negative breast cancer. In metastatic disease, the Algerian 2026 ...
Favorable Outcomes With Synchronous Biopsy and Cryoablation for Suspicious Pulmonary Nodules / cancer, Joel Schein, OncoDaily ...
PERSEE Trial leaves Questions About PD-L1 Expression and Immunotherapy Outcomes / cancer, cancer care, cancer treatment, ...
How University Hospitals Can Strengthen Cancer Prevention and Early Detection Through CAPER / AACR 2026, Ahmed Gewil, Alaa ...
Bladder Cancer Edition Part 2 / advanced urothelial carcinoma, Andrea Necchi, Antibody drug conjugates, Astellas, bladder ...
Who Decides the Future of Cancer Care? / Artificial Intelligence in Oncology, Big Questions in Oncology, cancer care, ...
Multiple Myeloma Symptoms, Treatment & Prognosis / blood cancer, Bone Lesions, Cancer in Younger Adults, Cassie ...
On October 25, 2026, OncoDaily Grand Rounds at ESMO 2026: Bladder Cancer Edition brought together leading oncology experts ...
What Happens After Neoadjuvant Therapy? / Algeria, Breast Cancer, breast oncology, cancer, HER2-positive breast ...
Day 3 / Aakash Desai, Andrea Necchi, Bishal Gyawali, Erika Ruiz-Garcia, Fagr Aboumadawy, Ippokratis Korantzis, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results